On the contrary, miR-3938 can downregulate the expression of mouse double minute 2 homolog (MDM2) to increase the expression of tumour-suppressor protein p53, leading to inhibition of glioblastoma progression [48]. The gene discussed is TP53; the disease is neoplasm.